Publicação
Investment committee paper: Gerresheimer Ag - valuation
| Resumo: | Gerresheimer is a leading medical device and packaging manufacturer for the pharma, cosmetics, and food & beverage sectors, and poses a unique investment opportunity. Gerresheimer operates a sophisticated procurement network that can be leveraged to perform a strategic shift towards the MedTech industry. This can be accomplished by carving-out its capex-heavy moulded glass division and using the proceeds to acquire leading players in this industry, namely Ypsomed and H&T Presspart, to also strengthen its recently established internal MedTech segment. This strategy is expected to realize a return of 3.8x (30.5% IRR), whereby the exit is likely to be a trade sale. |
|---|---|
| Autores principais: | Bursche, Maximilian |
| Assunto: | Gerresheimer Lbo Buy-and build Carve-out Valuation |
| Ano: | 2023 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | Gerresheimer is a leading medical device and packaging manufacturer for the pharma, cosmetics, and food & beverage sectors, and poses a unique investment opportunity. Gerresheimer operates a sophisticated procurement network that can be leveraged to perform a strategic shift towards the MedTech industry. This can be accomplished by carving-out its capex-heavy moulded glass division and using the proceeds to acquire leading players in this industry, namely Ypsomed and H&T Presspart, to also strengthen its recently established internal MedTech segment. This strategy is expected to realize a return of 3.8x (30.5% IRR), whereby the exit is likely to be a trade sale. |
|---|